Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Both medications represent the cutting edge of obesity and diabetes treatment, but they're at different stages of availability
If GLP-1 receptor agonists are the foundation, theyre committed to stacking innovation brick by brick until theyve constructed something extraordinary
19 When fluctuations are severe within a single weight cycle ( 9 kg), the risk of requiring a cholecystectomy increases by up to 68% in women
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: an 8-month prospective study
However, GLP-1RAs should be considered as the preferential add-on therapy in T2DM patients with CKD in case of persistent albuminuria and/or uncontrolled metabolic risks (i.e., inadequate glycemic control, hypertension, overweight/obesity)
Patients who commit to and maintain lifestyle changes in diet and exercise are more likely to keep a substantial amount of the weight off after discontinuing GLP-1 medications
